Baird Financial Group, Inc. Cognition Therapeutics Inc Transaction History
Baird Financial Group, Inc.
- $47.6 Billion
- Q2 2024
A detailed history of Baird Financial Group, Inc. transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 22,393 shares of CGTX stock, worth $9,852. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,393
Previous 22,393
-0.0%
Holding current value
$9,852
Previous $40,000
7.5%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CGTX
# of Institutions
50Shares Held
7.62MCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$970,3650.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$504,9230.0% of portfolio
-
Awm Investment Company, Inc. New York, NY650KShares$286,0000.17% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$220,0000.01% of portfolio
-
Timelo Investment Management Inc.361KShares$159,0140.35% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $9.99M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...